Vilin Bio Med reclassifies outgoing promoter to public
Vilin Bio Med Limited reclassified outgoing promoter Mr. Devireddy Srinivas Reddy to the public category after an open offer concluded on September 15, 2025. Reddy holds 4,45,425 equity shares, representing 3.19% of the total voting capital. The move complies with SEBI LODR Regulation 31A(10).
*this image is generated using AI for illustrative purposes only.
Vilin Bio Med Limited has completed the reclassification of its outgoing promoter to the public category. This action follows the successful conclusion of an open offer for the acquisition of 26% of the voting share capital, which finalized on September 15, 2025. The management and control of the company have subsequently been transferred to the new acquirer(s), who have been classified as the new promoter(s).
The reclassification utilizes the exemption provided under Regulation 31A(10) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that Mr. Devireddy Srinivas Reddy, the outgoing promoter, satisfies all necessary conditions specified in the regulation for this change in status.
Details of Reclassification
The outgoing promoter has ceased to exercise control over the affairs of the company and does not hold any special rights. The certification confirms compliance with specific regulatory requirements regarding shareholding and governance.
| Name of the Outgoing Promoter | Number of Equity Shares Held | % of Total Voting Capital |
|---|---|---|
| Mr. Devireddy Srinivas Reddy | 4,45,425 | 3.19 |
Regulatory Compliance
The company certified that the outgoing promoter does not hold more than 10% of the total voting rights and is not represented on the Board of Directors. Additionally, the individual shall not act as a Key Managerial Person for a period of three years from the date of reclassification. The confirmation also states that the promoter is not a wilful defaulter or a fugitive economic offender as per relevant guidelines.
Historical Stock Returns for Vilin Bio Med
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| 0.0% | -2.06% | +29.43% | +124.59% | +88.12% | +66.67% |
How might the new acquirer(s) restructure Vilin Bio Med Limited's business strategy and operations following the completion of management control transfer?
What are the potential implications for Vilin Bio Med Limited's stock performance and investor sentiment now that the ownership transition is fully formalized?
Could Mr. Devireddy Srinivas Reddy's remaining 3.19% stake influence future corporate decisions once the three-year KMP restriction period expires?
19
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
